Jiangxi Fushine Pharmaceutical Co Ltd (300497) — Capital Reinvestment Ratio
Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Capital Reinvestment Ratio of 2.35x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥18.31 Million) in capital expenditures (CN¥43.04 Million). See free cash flow generation of Jiangxi Fushine Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangxi Fushine Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Jiangxi Fushine Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see market value of Jiangxi Fushine Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.59x | CN¥62.67 Million | CN¥224.88 Million | ▲ +375.0% |
| 2024 | 0.76x | CN¥187.64 Million | CN¥141.75 Million | ▼ -92.0% |
| 2021 | 9.40x | CN¥72.32 Million | CN¥679.60 Million | ▲ +699.8% |
| 2020 | 1.17x | CN¥382.35 Million | CN¥449.24 Million | ▲ +22.2% |
| 2019 | 0.96x | CN¥337.91 Million | CN¥324.90 Million | ▲ +3.2% |
| 2018 | 0.93x | CN¥175.91 Million | CN¥163.89 Million | ▲ +98.3% |
| 2017 | 0.47x | CN¥210.72 Million | CN¥98.99 Million | ▲ +8.9% |
| 2016 | 0.43x | CN¥188.53 Million | CN¥81.34 Million | ▼ -56.7% |
| 2015 | 1.00x | CN¥74.01 Million | CN¥73.74 Million | ▼ -39.7% |
| 2014 | 1.65x | CN¥31.39 Million | CN¥51.86 Million | ▲ +25.0% |
| 2013 | 1.32x | CN¥57.22 Million | CN¥75.60 Million | ▲ +62.9% |
| 2012 | 0.81x | CN¥63.20 Million | CN¥51.24 Million | ▼ -66.7% |
| 2011 | 2.43x | CN¥33.80 Million | CN¥82.21 Million | — |